Completed NA INTERVENTIONAL 2-arm NCT06074965

Impact of Two Medtronic Infusion Sets on Lipohypertrophy in Type 1 Diabetes (T1DM) Patients Thought to Have LH

The Impact of Two Medtronic Infusion Sets (a 3-day Set & a 7-day Set) on Lipohyperthrophy (LH) in Persons With Type 1 Diabetes (T1D) and Thought to Have LH

Sponsor: Azienda Ospedaliera San Camillo Forlanini

Conditions Diabetes Diabetes Mellitus, Type 1 Lipohypertrophy

Interventions Medtronic Extended Infusion Set

Updated 3 times since 2023 Last updated: Oct 6, 2023 Started: Oct 5, 2022 Primary completion: May 23, 2023 Completion: May 23, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Diabetes and Diabetes Mellitus, Type 1, this trial is completed. The trial is conducted by Azienda Ospedaliera San Camillo Forlanini and has accumulated 3 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Nov 2023 — Jul 2024 [monthly]

Completed NA

First recorded

Oct 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azienda Ospedaliera San Camillo Forlanini
Medtronic

Data source: Azienda Ospedaliera San Camillo Forlanini

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Roma, Italy